NCT06328374

Brief Summary

This research study is investigating whether people with Alzheimer's disease experience more changes to voice and swallowing than their healthy age-matched peers. The prevalence of swallowing impairments in moderate-severe Alzheimer's Disease is high (85-93%) and voice is also often negatively impacted by Alzheimer's disease. The overall objective of this study is to evaluate the voice and swallowing function of adults with and without Alzheimer's disease. The investigators will also be involving the primary caregivers of individuals with Alzheimer's that are enrolled in the study to better understand the impact of voice and swallowing impairments on the primary caregivers of those with Alzheimer's Disease. Healthy adults and individuals with Alzheimer's disease will:

  • undergo tests of cough, voice, and swallow function
  • undergo tests of grip and tongue strength
  • complete questionnaires Caregivers of individuals with Alzheimer's disease will also complete questionnaires.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2024

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 25, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

November 5, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2024

Completed
Last Updated

November 7, 2024

Status Verified

November 1, 2024

Enrollment Period

Same day

First QC Date

March 18, 2024

Last Update Submit

November 5, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Swallowing safety

    The penetration aspiration scale is a validated 8-point ordinal rating scale that measures the depth of airway invasion and the patient's response during swallowing. Scores range from 1 to 8 with a score of 1 indicating a safe swallow (best score) and 8 indicating silent aspiration (worst score).

    During baseline visit at time of enrollment.

  • Voluntary cough peak expiratory flow

    A measure of cough strength

    During baseline visit at time of enrollment.

  • Vocal fold bowing index

    Vocal fold bowing will be completed as described by Bloch and Behrman.

    During baseline visit at time of enrollment.

Secondary Outcomes (9)

  • Swallowing and Eating Related Fatigue Questionnaire (SERF)

    During baseline visit at time of enrollment, 1 year after baseline visit, 2 years after baseline visit.

  • Swallowing Related Quality of Life Questionnaire (SWAL-QOL)

    During baseline visit at time of enrollment, 1 year after baseline visit, 2 years after baseline visit.

  • Voice Handicap Index (VHI)

    During baseline visit at time of enrollment, 1 year after baseline visit, 2 years after baseline visit.

  • Aging Voice Index (AVI)

    During baseline visit at time of enrollment, 1 year after baseline visit, 2 years after baseline visit.

  • Grip Strength

    During baseline visit at time of enrollment.

  • +4 more secondary outcomes

Study Arms (2)

Healthy community dwelling adults

Healthy adults between the ages of 60-100 with no prior history of neurological, respiratory, or gastrointestinal diseases or swallowing or voice impairments, or history of head and neck surgery, cancer, or radiation to the head or neck will be enrolled in this study.

Adults with Alzheimer's Disease and their caregivers

Adults with a diagnosis of Alzheimer's disease and their caregivers will be enrolled in this study.

Eligibility Criteria

Age60 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The overall objective of this proposal is to evaluate voice and swallow function in 40 healthy adults and 40 individuals with AD and to evaluate caregiver perceptions of voice and swallow function and burden in 40 caregivers of individuals with AD. Thus, this study will enroll healthy adults, individuals with AD, and caregivers of individuals with AD.

You may qualify if:

  • healthy community dwelling adult (60-100 years old)
  • no prior history of neurological diseases
  • no prior history of respiratory diseases
  • no prior history of head and neck surgery/head and neck cancer/radiation to head and neck region
  • no prior history of swallowing difficulties
  • no prior history of gastroesophageal diseases/impairments
  • absence of vocal fold lesions or paresis/paralysis
  • no recent intubation (≥3 weeks)
  • score ≥26 on the Montreal Cognitive Assessment (MOCA) or the telephone version of the MOCA (t-MOCA)

You may not qualify if:

  • individual \<60 years old, \>100 years old
  • history of neurological disease
  • history of respiratory disease
  • history of head and neck surgery/head and neck cancer/radiation to head and neck region
  • history of swallowing difficulties
  • history of gastroesophageal diseases/impairments
  • presence of vocal fold lesions or paresis/paralysis
  • recent intubation (\<3 weeks)
  • score \<26 on the Montreal Cognitive Assessment (MOCA) or the telephone version of the MOCA (t-MOCA)
  • AD Cohort
  • between 60-100 years old
  • diagnosis of AD by neurologist
  • consuming some form of oral intake
  • able to follow basic directions
  • individual \<60 years old, \>100 years old
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Alzheimer DiseaseCaregiver BurdenDysphoniaDeglutition Disorders

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersStress, PsychologicalBehavioral SymptomsBehaviorVoice DisordersLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal Diseases
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Director of Medical Speech-Language Pathology

Study Record Dates

First Submitted

March 18, 2024

First Posted

March 25, 2024

Study Start

November 5, 2024

Primary Completion

November 5, 2024

Study Completion

November 5, 2024

Last Updated

November 7, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share